Association of Prognostic Understanding With Health Care Use Among Older Adults With Advanced Cancer
Authors: Kah Poh Loh, Christopher L. Seplaki, Chandrika Sanapala, Reza Yousefi-Nooraie, Jennifer L. Lund, Ronald M. Epstein, Paul R. Duberstein, Marie Flannery, Eva Culakova, Huiwen Xu, Colin McHugh, Heidi D Klepin, Po-Ju Lin, Erin Watson, Valerie Aarne Grossman, Jane Jijun Liu, Jodi Geer, Mark A. O’Rourke, Karen Mustian, Supriya G. Mohile
Journal: JAMA Network Open (2022)

<h3>Importance</h3> A poor prognostic understanding regarding curability is associated with lower odds of hospice use among patients with cancer. However, the association between poor prognostic understanding or prognostic discordance and health care use among older adults with advanced incurable cancers is not well characterized. <h3>Objective</h3> To evaluate the association of poor prognostic understanding and patient-oncologist prognostic discordance with hospitalization and hospice use among older adults with advanced cancers. <h3>Design, Setting, and Participants</h3> This was a post hoc secondary analysis of a cluster randomized clinical trial that recruited patients from October 29, 2014, to April 28, 2017. Data were collected from community oncology practices affiliated with the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program. The parent trial enrolled 541 patients who were aged 70 years or older and were receiving or considering any line of cancer treatment for incurable solid tumors or lymphomas; the patients' oncologists and caregivers (if available) were also enrolled. Patients were followed up for at least 1 year. Data were analyzed from January 3 to 16, 2021. <h3>Main Outcomes and Measures</h3> At enrollment, patients and oncologists were asked about their beliefs regarding cancer curability (100%, &gt;50%, 50%, &lt;50%, and 0%; answers other than 0% reflected poor prognostic understanding) and life expectancy (≤6 months, 7-12 months, 1-2 years, 2-5 years, and &gt;5 years; answers of &gt;5 years reflected poor prognostic understanding). Any difference between oncologist and patient in response options was considered discordant. Outcomes were any hospitalization and hospice use at 6 months captured by the clinical research associates. <h3>Results</h3> Among the 541 patients, the mean (SD) age was 76.6 (5.2) years, 264 of 540 (49%) were female, and 486 of 540 (90%) were White. Poor prognostic understanding regarding curability was reported for 59% (206 of 348) of patients, and poor prognostic understanding regarding life expectancy estimates was reported for 41% (205 of 496) of patients. Approximately 60% (202 of 336) of patient-oncologist dyads were discordant regarding curability, and 72% (356 of 492) of patient-oncologist dyads were discordant regarding life expectancy estimates. Poor prognostic understanding regarding life expectancy estimates was associated with lower odds of hospice use (adjusted odds ratio, 0.30; 95% CI, 0.16-0.59). Discordance regarding life expectancy estimates was associated with greater odds of hospitalization (adjusted odds ratio, 1.64; 95% CI, 1.01-2.66). <h3>Conclusions and Relevance</h3> This study highlights different constructs of prognostic understanding and the need to better understand the association between prognostic understanding and health care use among older adult patients with advanced cancer. <h3>Trial Registration</h3> ClinicalTrials.gov Identifier:NCT02107443